Health Catalyst (HCAT) Liabilities and Shareholders Equity (2018 - 2026)

Health Catalyst (HCAT) has 9 years of Liabilities and Shareholders Equity data on file, last reported at $412.2 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 53.77% year-over-year to $412.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 billion (down 34.93% YoY) and the FY2025 annual result came in at $502.6 million, down 41.48% from the prior year.
• Liabilities and Shareholders Equity declined to $412.2 million in Q1 2026, from $502.6 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $891.5 million in Q1 2025 to a low of $412.2 million in Q1 2026.
• A 5-year average of $713.1 million and a median of $722.9 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity jumped 44.41% — and 2026, when it tumbled 53.77%.
• Tracing HCAT's Liabilities and Shareholders Equity over 5 years: stood at $752.3 million in 2022, then declined by 6.71% to $701.8 million in 2023, then advanced by 22.39% to $858.9 million in 2024, then plunged by 41.48% to $502.6 million in 2025, then retreated by 17.99% to $412.2 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $412.2 million (Q1 2026), $502.6 million (Q4 2025), and $587.1 million (Q3 2025), per Business Quant data.